Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Mycotoxin Res ; 36(2): 235-241, 2020 May.
Article in English | MEDLINE | ID: mdl-31981090

ABSTRACT

Ochratoxin A is one of the most diffused mycotoxin present in a large spectrum of food commodities, mainly produced by Aspergillus ochraceus, Aspergillus carbonarius, Aspergillus niger and Penicillium verrucosum. EU has set maximum limits for a number of matrices such as cereals, wine, spices and liquorice, whilst other commodities such as beer and meat products that are susceptible of OTA contamination and are largely consumed are not included. In 2013, within the framework of the Regulation (EC) 882/2004 on official controls, the European Commission issued the mandate M/520 regarding the standardisation for methods of analysis for mycotoxins in food to the European Committee for Standardisation. Of the 11 priorities of the mandate, the one on "HPLC determination of OTA in meat, meat products and edible offal" was assigned to the Italian National Reference Laboratory for feed and food. The method was single-laboratory validated, and all the performance characteristics of the method were compliant with the corresponding reference values indicated in Regulation (EC) n. 401/2006. The method was applied to characterise a set of 5 pork-based materials (ham, kidney, liver and canned chopped pork) to be used for an inter-laboratory method validation study. Three ham materials (levels of contamination of 0.77, 2.22 and 12.3 µg/kg, respectively), one liver material (contamination level of 2.80 µg/kg) and one chopped pork meat (contamination level of 0.66 µg/kg) were tested for homogeneity and stability.


Subject(s)
Food Analysis/methods , Food Contamination/prevention & control , Ochratoxins/analysis , Pork Meat/analysis , Animals , Chromatography/methods , Chromatography, High Pressure Liquid , Food Contamination/analysis , Swine
2.
Foods ; 8(5)2019 May 01.
Article in English | MEDLINE | ID: mdl-31052444

ABSTRACT

Genus Claviceps is a plant pathogen able to produce a group of toxins, ergot alkaloids (EAs), whose effects have been known since the Middle Ages (ergotism). Claviceps purpurea is the most important representative specie, known to infect more than 400 monocotyledonous plants including economically important cereal grains (e.g., rye, wheat, triticale). EAs are not regulated as such. Maximum limits are in the pipeline of the EU Commission while at present ergot sclerotia content is set by the Regulation (EC) No. 1881/2006 in unprocessed cereals (0.05% as a maximum). This study aimed to investigate the presence of the six principal EAs (ergometrine, ergosine, ergocornine, α-ergocryptine, ergotamine and ergocristine) and their relative epimers (-inine forms) in rye- and wheat-based products. Of the samples, 85% resulted positive for at least one of the EAs. Wheat bread was the product with the highest number of positivity (56%), followed by wheat flour (26%). Rye and wheat bread samples showed the highest values when the sum of the EAs was considered, and durum wheat bread was the more contaminated sample (1142.6 µg/kg). These results suggest that ongoing monitoring of EAs in food products is critical until maximum limits are set.

3.
Toxins (Basel) ; 9(7)2017 06 29.
Article in English | MEDLINE | ID: mdl-28661468

ABSTRACT

Environmental factors and genetic susceptibility are implicated in the increased risk of autism spectrum disorder (ASD). Mycotoxins are agricultural contaminants of fungal origin that represent real risk factors for human health and especially for children. Thus, the main hypothesis of this work is that the deterioration of the clinical manifestation of autism in children may result from the exposure to mycotoxins through the consumption of contaminated food. Within a cross-sectional study, a group of autistic children (n = 172) and a group of controls (n = 61) (siblings and non-parental) were recruited in North and South Italy. All children had blood and urine samples taken, for testing some mycotoxins by a LC-MS/MS validated method. Blood samples were also tested for assessing specific IgG against food and fungal antigens and cytokines. The analyses outputs highlighted statistically significant differences comparing mycotoxins levels between (i) children groups both in urine (deoxynivalenol and de-epoxydeoxynivalenol, p = 0.0141 and p = 0.0259, respectively) and serum (aflatoxin M1, ochratoxin A and fumonisin B1, p = 0.0072, p = 0.0141 and p = 0.0061, respectively); (ii) a group of selected fungal IgGs, and IgGs against wheat and gluten and (iii) cytokines. These results suggest the need for a deeper examination of the role that mycotoxins may have on the etiology of ASD.


Subject(s)
Autism Spectrum Disorder/blood , Autism Spectrum Disorder/urine , Mycotoxins/blood , Mycotoxins/urine , Antibodies, Fungal/immunology , Antigens, Fungal/immunology , Autism Spectrum Disorder/immunology , Child , Child, Preschool , Cytokines/blood , Cytokines/urine , Environmental Exposure/analysis , Female , Glutens/immunology , Humans , Immunoglobulin G/immunology , Male , Triticum/immunology
4.
Toxins (Basel) ; 9(5)2017 05 18.
Article in English | MEDLINE | ID: mdl-28524101

ABSTRACT

The analytical scenario for determining contaminants in the food and feed sector is constantly prompted by the progress and improvement of knowledge and expertise of researchers and by the technical innovation of the instrumentation available. Mycotoxins are agricultural contaminants of fungal origin occurring at all latitudes worldwide and being characterized by acute and chronic effects on human health and animal wellness, depending on the species sensitivity. The major mycotoxins of food concern are aflatoxin B1 and ochratoxin A, the first for its toxicity, and the second for its recurrent occurrence. However, the European legislation sets maximum limits for mycotoxins, such as aflatoxin B1, ochratoxin A, deoxynivalenol, fumonisins, and zearalenone, and indicative limits for T-2 and HT-2 toxins. Due to the actual probability that co-occurring mycotoxins are present in a food or feed product, nowadays, the availability of reliable, sensitive, and versatile multi-mycotoxin methods is assuming a relevant importance. Due to the wide range of matrices susceptible to mycotoxin contamination and the possible co-occurrence, a multi-mycotoxin and multi-matrix method was validated in liquid chromatography-tandem mass spectrometry (LC-MS/MS) with the purpose to overcome specific matrix effects and analyze complex cereal-based samples within the Italian Total Diet Study project.


Subject(s)
Edible Grain/chemistry , Food Contamination/analysis , Mycotoxins/analysis , Bread/analysis , Chromatography, Liquid , Flour/analysis , Oryza/chemistry , Tandem Mass Spectrometry , Triticum/chemistry
5.
Nanotoxicology ; 8(6): 654-62, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23834344

ABSTRACT

The study explored possible reproductive and endocrine effects of short-term (5 days) oral exposure to anatase TiO2 nanoparticles (0, 1, 2 mg/kg body weight per day) in rat. Nanoparticles were characterised by scanning electron microscopy (SEM) and transmission electron microscopy, and their presence in spleen, a target organ for bioaccumulation, was investigated by single-particle inductively coupled plasma mass spectrometry and SEM/energy-dispersive X-ray. Analyses included serum hormone levels (testosterone, 17-ß-estradiol and triiodothyronine) and histopathology of thyroid, adrenals, ovary, uterus, testis and spleen. Increased total Ti tissue levels were found in spleen and ovaries. Sex-related histological alterations were observed at both dose levels in thyroid, adrenal medulla, adrenal cortex (females) and ovarian granulosa, without general toxicity. Altered thyroid function was indicated by reduced T3 (males). Testosterone levels increased in high-dose males and decreased in females. In the spleen of treated animals TiO2 aggregates and increased white pulp (high-dose females) were detected, even though Ti tissue levels remained low reflecting the low doses and the short exposure time. Our findings prompt to comprehensively assess endocrine and reproductive effects in the safety evaluation of nanomaterials.


Subject(s)
Gonadal Steroid Hormones/blood , Metal Nanoparticles/toxicity , Spleen/drug effects , Thyroid Hormones/blood , Titanium/toxicity , Administration, Oral , Animals , Apoptosis/drug effects , Eating/drug effects , Female , Male , Metal Nanoparticles/administration & dosage , Ovary/chemistry , Ovary/drug effects , Rats , Rats, Sprague-Dawley , Spleen/chemistry , Thyroid Gland/chemistry , Thyroid Gland/drug effects , Tissue Distribution , Titanium/administration & dosage , Weight Gain/drug effects
6.
Ann Ist Super Sanita ; 49(3): 272-80, 2013.
Article in English | MEDLINE | ID: mdl-24071607

ABSTRACT

This article presents the methodology of the Italian Total Diet Study 2012-2014 aimed at assessing the dietary exposure of the general Italian population to selected nonessential trace elements (Al, inorganic As, Cd, Pb, methyl-Hg, inorganic Hg, U) and radionuclides (40K, 134Cs, 137Cs, 90Sr). The establishment of the TDS food list, the design of the sampling plan, and details about the collection of food samples, their standardized culinary treatment, pooling into analytical samples and subsequent sample treatment are described. Analytical techniques and quality assurance are discussed, with emphasis on the need for speciation data and for minimizing the percentage of left-censored data so as to reduce uncertainties in exposure assessment. Finally the methodology for estimating the exposure of the general population and of population subgroups according to age (children, teenagers, adults, and the elderly) and gender, both at the national level and for each of the four main geographical areas of Italy, is presented.


Subject(s)
Diet , Radioisotopes/analysis , Trace Elements/analysis , Adolescent , Adult , Data Collection , Diet Surveys , Food Analysis , Humans , Italy , Quality Control , Risk Assessment
7.
Food Chem Toxicol ; 59: 261-71, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23774258

ABSTRACT

Ethylenethiourea (ETU) is the common metabolite of the widely used ethylenebisdithiocarbamate fungicides. It is identified as Endocrine Disruptor given its ability to interfere with thyroid hormone biosynthesis by inhibiting thyroid peroxidase activity. As far as we know, no studies have been performed to assess potential effects of ETU exposure at low dose levels, i.e. below the established LOAEL and NOAEL, during critical phases of development. Therefore, the aim of the present study was to verify the short- and long-term effects on thyroid function, reproduction and development of oral exposure to ETU levels comparable to and lower than LOAEL/NOAEL in rats. Sixty dams were treated daily by gavage during pregnancy and lactation with 0, 0.1, 0.3, 1.0 mg/kg bw per day of ETU. F1 generation was similarly treated from weaning to sexual maturity. Thyroid biomarkers were analyzed in dams and in offspring. Reproductive biomarkers were analyzed in F1 rats. For the first time this study has demonstrated reproductive toxicity and hypothyroidism at a lower than LOAEL dose exposure in pregnant dams and F1 generation. Our data suggest that even low doses of ETU can interfere with thyroid homeostasis and reproductive hormone profile if exposure starts in critical stages of development.


Subject(s)
Endocrine Disruptors/toxicity , Ethylenethiourea/toxicity , Hypothyroidism/chemically induced , Infertility, Female/chemically induced , Infertility, Male/chemically induced , Prenatal Exposure Delayed Effects , Thyroid Gland/drug effects , Administration, Oral , Animals , Biomarkers/blood , Biomarkers/metabolism , Congenital Hypothyroidism/chemically induced , Congenital Hypothyroidism/physiopathology , Dose-Response Relationship, Drug , Endocrine Disruptors/administration & dosage , Estradiol Congeners/blood , Ethylenethiourea/administration & dosage , Female , Fungicides, Industrial/metabolism , Fungicides, Industrial/toxicity , Hypothyroidism/blood , Hypothyroidism/pathology , Hypothyroidism/physiopathology , Infertility, Female/blood , Infertility, Male/blood , Lactation , Male , Pesticide Residues/toxicity , Pregnancy , Rats , Rats, Sprague-Dawley , Testosterone Congeners/blood , Thyroid Gland/pathology , Thyroid Gland/physiopathology
8.
Reprod Toxicol ; 29(4): 427-32, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20307648

ABSTRACT

The plasticizer di-(2-ethylhexyl)phthalate (DEHP) affects reproductive development, glycogen and lipid metabolism. Whereas liver is a main DEHP target in adult rodents, the potential impact on metabolic programming is unknown. Effects of in utero DEHP exposure on liver development were investigated upon treatment of pregnant CD-1 mice on gestational days (GD)11-19. F1 mice were examined at post-natal days 21 (weaning) and 35 (start of puberty): parameters included liver histopathological, immunocytochemical and alpha-fetoprotein (AFP) gene expression analyses. In utero DEHP exposure altered post-natal liver development in weanling mice causing significant, dose-related (i) increased hepatosteatosis, (ii) decreased glycogen storage, (iii) increased beta-catenin intracytoplasmic localization (females only). At puberty, significantly decreased glycogen storage was still present in males. A treatment-induced phenotype was identified with lack of glycogen accumulation and intracytoplasmic localization of beta-catenin which was associated with increased AFP gene expression. Our findings suggested that DEHP alters post-natal liver development delaying the programming of glycogen metabolism.


Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Diethylhexyl Phthalate/toxicity , Environmental Pollutants/toxicity , Fatty Liver/chemically induced , Liver/drug effects , Prenatal Exposure Delayed Effects/chemically induced , Animals , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Cytoplasm/metabolism , Fatty Liver/metabolism , Fatty Liver/pathology , Female , Gene Expression/drug effects , Liver/growth & development , Liver/metabolism , Liver Glycogen/metabolism , Maternal Exposure , Mice , Mice, Inbred Strains , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , RNA, Messenger/metabolism , alpha-Fetoproteins/genetics , alpha-Fetoproteins/metabolism , beta Catenin/metabolism
9.
Toxicol Sci ; 108(2): 311-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19190125

ABSTRACT

Organophosphorus insecticides, as Chlorpyrifos (CPF), are widely used in agriculture and against household pests; these compounds receive an increasing consideration as potential endocrine disrupters. The aim of the present study was to examine the potential short- and long-term effects of CPF on thyroid and adrenal glands in CD1 mice following exposure at dose levels not inducing brain acetyl cholinesterase (AchE) inhibition, during gestational and/or postnatal vulnerable phases. Pregnant dams were treated with 0, 3, 6 mg/kg bw/day of CPF on gestational days 15-18. After delivery, pups were treated subcutaneously on postnatal days (PND) 11-14 with: 0, 1, 3 mg/kg bw/day of CPF. Serum thyroxin (T4), thyroid and adrenals histology and histomorphometry were evaluated in dams and in F1 mice. In dams at 6 mg/kg, decreased T4 levels and increased cell height in thyroid were observed, and adrenal histology showed a slightly increased vacuolization in the X-zone. In the F1, short-term morphological modifications (reduced follicular size at PND 2) and long-term morphological (increased necrotic follicular cells) and biochemical alterations (reduced serum T4 levels) were found at PND 150 with an apparent higher vulnerability of males. For the first time these results indicate that CPF exposure at dose levels not inducing brain AchE inhibition causes thyroid alterations in dams and in F1 CD1 mice. Thyroid may be a sensitive target to CPF developmental exposure possibly leading to long-term effects on thyroid function. Because thyroid plays a pivotal role in mammalian development, these findings can be relevant to humans.


Subject(s)
Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Endocrine Disruptors/toxicity , Insecticides/toxicity , Thyroid Gland/growth & development , Thyroid Hormones/biosynthesis , Adrenal Gland Diseases/chemically induced , Adrenal Gland Diseases/pathology , Adrenal Glands/growth & development , Adrenal Glands/pathology , Animals , Animals, Newborn , Brain/drug effects , Brain/enzymology , Epithelial Cells/drug effects , Epithelial Cells/pathology , Female , Male , Mice , Pregnancy , Thyroid Gland/metabolism , Thyroid Gland/pathology , Thyroxine/blood , Triiodothyronine/blood
10.
Reprod Toxicol ; 26(2): 146-50, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18692564

ABSTRACT

The synthetic estrogen diethylstilbestrol (DES) is a model to study the effects on female reproductive tract of endocrine disrupting chemicals interacting with estrogen receptors. Pregnant CD-1 mice were given daily by gavage 10microg/kg bw of DES (the lower range of therapeutic exposure) during gestational days 9-16, critical period for reproductive tract development. Parameters of sexual development were recorded after weaning and at sexual maturation. No signs of general toxicity were observed in dams. In DES-treated group, reduced litter weight during lactation and earlier vaginal patency was observed. Uterus weight was increased in F1 treated females at weaning. Histological analysis showed reduced endometrium thickness and increased polyovular follicles, irregular and oocytes with condensed chromatin in the ovary at sexual maturity. Prenatal DES oral administration induces subtle but significant effects on puberty onset, uterine and ovary morphology.


Subject(s)
Diethylstilbestrol/toxicity , Estrogens, Non-Steroidal/toxicity , Genitalia, Female , Prenatal Exposure Delayed Effects/chemically induced , Administration, Oral , Animals , Dose-Response Relationship, Drug , Female , Genitalia, Female/drug effects , Genitalia, Female/growth & development , Genitalia, Female/pathology , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/growth & development , Mammary Glands, Animal/pathology , Mice , Mice, Inbred Strains , Ovary/drug effects , Ovary/growth & development , Ovary/pathology , Pregnancy , Prenatal Exposure Delayed Effects/physiopathology , Uterus/drug effects , Uterus/growth & development , Uterus/pathology , Vagina/drug effects , Vagina/growth & development , Vagina/pathology
11.
Recenti Prog Med ; 94(2): 69-74, 2003 Feb.
Article in Italian | MEDLINE | ID: mdl-12908373

ABSTRACT

A reduced incidence or the regression of Kaposi's sarcoma (KS) has been described in HIV-infected patients treated with HIV-protease inhibitors (PI). We have recently demonstrated that PI block the angiogenesis and the development of KS lesions induced experimentally in vivo by the inoculation of angiogenic factors or human primary KS cells. These effects of PI occur at the same drug concentrations in plasma of treated individuals, and they are due to the inhibition of cell invasion and of the activation of matrix metalloprotease-2, an enzyme that is key to angiogenesis and tumor growth and invasion. Since PI also block the production of cytokines involved in KS initiation and maintenance, this anti-inflammatory activity of PI may also contribute to the anti-KS effects observed in treated individuals. Thus, by direct and indirect activities PI can simultaneously block several pathways involved in tumor growth, invasion or metastasis. These data indicate that PI should also be investigated and exploited for the therapy of KS and tumors of different histology occurring in non infected individuals.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Sarcoma, Kaposi/drug therapy , Enzyme Activation , HIV Infections/complications , HIV Protease Inhibitors/blood , HIV Protease Inhibitors/pharmacology , Humans , Indinavir/therapeutic use , Matrix Metalloproteinase 2/metabolism , Neovascularization, Pathologic , Saquinavir/therapeutic use , Sarcoma, Kaposi/blood , Sarcoma, Kaposi/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...